Founded in 2002, by President William J. Clinton and Ira C. Magaziner, the Clinton Health Access Initiative, Inc. (“CHAI”) is a global health organization committed to saving lives, reducing the burden of disease and strengthening integrated health systems in the developing world. For more information, please visit: www.clintonhealthaccess.org.
The hallmark of CHAI’s approach is simultaneous and intensive engagement on the demand and supply sides of the market. On the demand side, CHAI’s country teams help governments to overcome barriers to scale up treatment and prevention programs. Meanwhile, the CHAI global access teams work to address supply-side barriers to access and foster a healthy marketplace to ensure the sustainable supply of essential medicines and diagnostic commodities. CHAI works to attract new suppliers, lower drug prices, encourage the adoption of stringent quality standards, and facilitate the uptake of important new or improved products. CHAI has played a particularly important role in the marketplace for pediatric antiretroviral therapy (ART), substantially expanding access to appropriate drugs and diagnostics to meet the unique needs of children.
CHAI’s Access Program works to address barriers to commodity access and to foster a healthy marketplace, fundamentally changing the economics of global health to ensure the sustainable supply of essential medicines and diagnostics. By securing lower prices for key commodities and improving laboratories in the developing world, we are helping patients access the treatment, care, and prevention services they need.
The HIV Prevention Country Support Manager (CSM) will support the HIV Access Program’s efforts to accelerate the development, introduction, and uptake of effective biomedical prevention interventions, within individual country contexts, to reduce new HIV infections in resource-limited settings. The CSM will work as part of the Prevention Market Manager grant, which is a multi-year project that CHAI is jointly implementing with AVAC. The CSM will drive country-level implementation of CHAI’s HIV prevention strategy, ensuring data-driven assessment, scale-up, and effective management of high-quality biomedical HIV prevention interventions, including oral PrEP and setting the stage for future technologies. Specifically, the CSM will travel frequently between countries, helping to optimize policies and processes to support the evaluation, adoption, introduction, and uptake of biomedical prevention options. The CSM will work to ensure that best practices are shared between countries and serve as a key connection between CHAI country teams and global HAP on reporting and other topics.
We are seeking a highly motivated individual with outstanding credentials, demonstrated project management experience, communication skills, and analytical ability. The candidate must be able to function independently and flexibly and have a strong commitment to excellence. CHAI places great value on relevant personal qualities: resourcefulness, responsibility, tenacity, independence, energy, and work ethic.
This role has flexibility to be based in another CHAI program country, pending country team leadership approval.